CHINA PHARMA HOLDINGS, INC. (CPHI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 30M 60M 90M Q4 '10: 74.4M Q1 '11: 77.4M Q2 '11: 80.4M Q3 '11: 82.7M Q4 '11: 81.2M Q1 '12: 79.1M Q2 '12: 74.1M Q3 '12: 65.3M Q4 '12: 54.5M Q1 '13: 46.7M Q2 '13: 40.1M Q3 '13: 36M Q4 '13: 32.8M Q1 '14: 31.7M Q2 '14: 29.8M Q3 '14: 27.2M Q4 '14: 22.1M Q1 '15: 20.7M Q2 '15: 20.3M Q3 '15: 19.2M Q4 '15: 20.4M Q1 '16: 18.3M Q2 '16: 16.2M Q3 '16: 14.8M Q4 '16: 15.6M Q1 '17: 15.2M Q2 '17: 14.6M Q3 '17: 14.6M Q4 '17: 13.2M Q1 '18: 13.5M Q2 '18: 13.8M Q3 '18: 12.9M Q4 '18: 12.3M Q1 '19: 11.6M Q2 '19: 11M Q3 '19: 11.1M Q4 '19: 10.9M Q1 '20: 9.8M Q2 '20: 11M Q3 '20: 11M Q4 '20: 10.9M Q1 '21: 11.5M Q2 '21: 10.1M Q3 '21: 9.7M Q4 '21: 9.6M Q1 '22: 8.9M Q2 '22: 8.1M Q3 '22: 8.1M Q4 '22: 8.1M Q1 '23: 8.5M Q2 '23: 7.9M Q3 '23: 7.8M Q4 '23: 7M Q1 '24: 6.4M Q2 '24: 6.2M Q3 '24: 5.5M Q4 '24: 4.5M Q1 '25: 4.3M Q2 '25: 4.4M Q3 '25: 4.1M Q4 '25: 4.1M Q1 '26: 4M Q2 '26: 3.9M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Gross Profit TTM

-15M 0 15M 30M 45M Q4 '10: 30.3M Q1 '11: 31M Q2 '11: 31.3M Q3 '11: 31.1M Q4 '11: 29M Q1 '12: 27.4M Q2 '12: 24.3M Q3 '12: 20M Q4 '12: 14.1M Q1 '13: 7.2M Q2 '13: 5.2M Q3 '13: 4.2M Q4 '13: -480.9K Q1 '14: 3.7M Q2 '14: 4M Q3 '14: 3.3M Q4 '15: 1.5M Q1 '16: 1M Q2 '16: 1.6M Q3 '16: 1.6M Q4 '16: 3.2M Q1 '17: 3.3M Q2 '17: 3.5M Q3 '17: 3.5M Q4 '17: 2.5M Q1 '18: 2.8M Q2 '18: 2.7M Q3 '18: 2.8M Q4 '19: 1.5M Q1 '20: 1M Q2 '20: 2M Q3 '20: 1.7M Q4 '20: 2M Q1 '21: 2M Q2 '21: 952.4K Q3 '21: 608.8K Q4 '21: 349.3K Q1 '22: -92.9K Q2 '22: -393.3K Q3 '22: -234.7K Q4 '22: -493.9K Q1 '23: -146.5K Q2 '23: -63.8K Q3 '23: -159.2K Q4 '23: -281.1K Q1 '24: -749K Q2 '24: -1.6M Q3 '24: -1.9M Q4 '24: -2M Q1 '25: -1.8M Q2 '25: -903.3K Q3 '25: -443.3K Q4 '25: -131.9K Q1 '26: 289.6K Q2 '26: 460.2K Q1 '12 Q4 '13 Q3 '16 Q2 '18 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Operating Income TTM

-45M -30M -15M 0 15M 30M 45M Q4 '10: 24.7M Q1 '11: 25.2M Q2 '11: 25M Q3 '11: 24.7M Q4 '11: 22M Q1 '12: 20.1M Q2 '12: 16.6M Q3 '12: 12.2M Q4 '13: -18.6M Q1 '14: -17.9M Q2 '14: -21.7M Q3 '14: -25M Q4 '14: -38.8M Q1 '15: -40.2M Q2 '15: -30.2M Q3 '15: -21M Q4 '15: -5.2M Q1 '16: -2.7M Q2 '16: -6.4M Q3 '16: -11.1M Q4 '16: -8.2M Q1 '17: -7.6M Q2 '17: -7.5M Q3 '17: -8.1M Q4 '17: -18.7M Q1 '18: -18M Q2 '18: -16.8M Q3 '18: -16.6M Q4 '18: -10.4M Q1 '19: -10.6M Q2 '19: -10.5M Q3 '19: -9.2M Q4 '19: -20.4M Q1 '20: -20.7M Q2 '20: -19.8M Q3 '20: -20.2M Q4 '20: -2.6M Q1 '21: -2.7M Q2 '21: -3.5M Q3 '21: -3.3M Q4 '21: -2.9M Q1 '22: -3.1M Q2 '22: -3.1M Q3 '22: -3M Q4 '22: -3.5M Q1 '23: -3M Q2 '23: -2.7M Q3 '23: -2.7M Q4 '23: -2.8M Q1 '24: -3.3M Q2 '24: -4.2M Q3 '24: -4.6M Q4 '24: -4.6M Q1 '25: -4.4M Q2 '25: -3.7M Q3 '25: -3.2M Q4 '25: -3.2M Q1 '26: -3.6M Q2 '26: -4.4M Q2 '11 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Net Income TTM

-45M -30M -15M 0 15M 30M 45M Q4 '10: 23.4M Q1 '11: 23.7M Q2 '11: 22.7M Q3 '11: 20M Q4 '11: 17.6M Q1 '12: 15.3M Q2 '12: 12M Q3 '12: 10M Q4 '13: -20M Q1 '14: -22.7M Q2 '14: -23.8M Q3 '14: -27.8M Q4 '14: -39.6M Q1 '15: -41.2M Q2 '15: -31.5M Q3 '15: -22.2M Q4 '15: -6.3M Q1 '16: -3.7M Q2 '16: -7.3M Q3 '16: -12M Q4 '16: -9.2M Q1 '17: -8.6M Q2 '17: -8.4M Q3 '17: -8.9M Q4 '17: -19.3M Q1 '18: -18.6M Q2 '18: -17.3M Q3 '18: -17M Q4 '18: -10.8M Q1 '19: -10.9M Q2 '19: -10.7M Q3 '19: -9.5M Q4 '19: -20.7M Q1 '20: -20.9M Q2 '20: -20.1M Q3 '20: -20.4M Q4 '20: -2.9M Q1 '21: -3M Q2 '21: -3.8M Q3 '21: -3.6M Q4 '21: -3.4M Q1 '22: -3.7M Q2 '22: -3.7M Q3 '22: -3.7M Q4 '22: -4M Q1 '23: -3.4M Q2 '23: -3.1M Q3 '23: -3.1M Q4 '23: -3.1M Q1 '24: -3.6M Q2 '24: -4.4M Q3 '24: -4.7M Q4 '24: -4.7M Q1 '25: -4.6M Q2 '25: -3.7M Q3 '25: -3.2M Q4 '25: -3.2M Q1 '26: -3.5M Q2 '26: -4.5M Q2 '11 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Cost of Revenue TTM

0 20M 40M 60M Q4 '10: 44.1M Q1 '11: 46.4M Q2 '11: 49.1M Q3 '11: 51.5M Q4 '11: 52.2M Q1 '12: 51.7M Q2 '12: 49.9M Q3 '12: 45.3M Q4 '12: 38.7M Q1 '13: 34M Q2 '13: 29.4M Q3 '13: 26.3M Q4 '13: 23.4M Q1 '14: 21.7M Q2 '14: 19.6M Q3 '14: 17.8M Q4 '14: 17.2M Q1 '15: 17.2M Q2 '15: 18M Q3 '15: 17.7M Q4 '15: 15.8M Q1 '16: 14.3M Q2 '16: 12.9M Q3 '16: 11.9M Q4 '16: 12.4M Q1 '17: 11.9M Q2 '17: 11.1M Q3 '17: 11.1M Q4 '17: 10.7M Q1 '18: 10.7M Q2 '18: 11.1M Q3 '18: 10.1M Q4 '18: 10.4M Q1 '19: 10.1M Q2 '19: 9.9M Q3 '19: 10.1M Q4 '19: 9.4M Q1 '20: 8.7M Q2 '20: 9M Q3 '20: 9.3M Q4 '20: 8.9M Q1 '21: 9.4M Q2 '21: 9.2M Q3 '21: 9.1M Q4 '21: 9.3M Q1 '22: 9M Q2 '22: 8.5M Q3 '22: 8.3M Q4 '22: 8.6M Q1 '23: 8.6M Q2 '23: 8M Q3 '23: 7.9M Q4 '23: 7.3M Q1 '24: 7.2M Q2 '24: 7.9M Q3 '24: 7.4M Q4 '24: 6.5M Q1 '25: 6.1M Q2 '25: 5.3M Q3 '25: 4.5M Q4 '25: 4.3M Q1 '26: 3.7M Q2 '26: 3.5M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating Cash Flow TTM

-4M 0 4M 8M 12M Q2 '11: 8.1M Q3 '11: 7.1M Q4 '11: 5.2M Q1 '12: 4.3M Q2 '12: 3.5M Q3 '12: 2.8M Q4 '12: 3.6M Q1 '13: 3M Q2 '13: 4.8M Q3 '13: 4.4M Q4 '13: 8.6M Q1 '14: 11.3M Q2 '14: 8M Q3 '14: 7.5M Q4 '14: 6.2M Q1 '15: 3.7M Q2 '15: 3.2M Q3 '15: 4.2M Q4 '15: 3.4M Q1 '16: 4.7M Q2 '16: 4.4M Q3 '16: 4.1M Q4 '16: 2.9M Q1 '17: 1.6M Q2 '17: 1.6M Q3 '17: 1.4M Q4 '17: 841.2K Q1 '18: 1.4M Q2 '18: 1.7M Q3 '18: 1.9M Q4 '18: 1.9M Q1 '19: 1.1M Q2 '19: 1.9M Q3 '19: 1.5M Q4 '19: 608.3K Q1 '20: 600.6K Q2 '20: 305.4K Q3 '20: -399.2K Q4 '20: -42.3K Q1 '21: -75K Q2 '21: 509.6K Q3 '21: 283.1K Q4 '21: -249.8K Q1 '22: -852.4K Q2 '22: -1.9M Q3 '22: -1.2M Q4 '22: -409.5K Q1 '23: -998.3K Q2 '23: -880.9K Q3 '23: -92.8K Q4 '23: -699.7K Q1 '24: 183.4K Q2 '24: 327.1K Q3 '24: -727.2K Q4 '25: 148.3K Q1 '26: 166.6K Q2 '26: -140.5K Q2 '11 Q2 '13 Q2 '15 Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '26

Free Cash Flow TTM

-21M -14M -7M 0 7M 14M 21M Q4 '11: 4.9M Q1 '12: 4M Q2 '12: 3.3M Q3 '12: 2.6M Q4 '12: 3.5M Q1 '13: 2.9M Q2 '13: 4.7M Q3 '13: -4.8M Q4 '13: -10.2M Q1 '14: -7.5M Q2 '14: -10.8M Q3 '14: -20.6M Q4 '14: 1M Q1 '15: -1.5M Q2 '15: -2.2M Q3 '15: -1.2M Q4 '15: 2.7M Q1 '16: 3.9M Q2 '16: 3.5M Q3 '16: 3.2M Q4 '16: 2.7M Q1 '17: 1.3M Q2 '17: 1.4M Q3 '17: 1.2M Q4 '17: 704.7K Q1 '18: 1.2M Q2 '18: 1.6M Q3 '18: 1.8M Q4 '18: 1.8M Q1 '19: 1M Q2 '19: 1.8M Q3 '19: 1.4M Q4 '19: 472.3K Q1 '20: 190.7K Q2 '20: -597.5K Q3 '20: -1.5M Q2 '22: -2.5M Q3 '22: -1.6M Q4 '25: 88.9K Q3 '12 Q4 '13 Q1 '15 Q2 '16 Q3 '17 Q4 '18 Q1 '20 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q3 '11: 43.5M Q1 '12: 43.5M Q2 '12: 43.6M Q3 '12: 43.6M Q1 '13: 43.6M Q2 '13: 43.6M Q1 '15: 43.6M Q2 '15: 43.6M Q3 '15: 43.6M Q1 '16: 43.6M Q2 '16: 43.6M Q3 '16: 43.6M Q1 '21: 45.6M Q2 '21: 45.6M Q3 '21: 46M Q1 '22: 4.7M Q2 '22: 4.8M Q3 '22: 5M Q1 '23: 8.1M Q2 '23: 1.7M Q3 '23: 2.6M Q1 '24: 1.3M Q2 '24: 1.6M Q3 '24: 1.7M Q1 '25: 3.3M Q2 '25: 3.2M Q3 '25: 3.9M Q1 '26: 25.6M Q2 '26: 40.5M Q3 '11 Q1 '13 Q3 '15 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q4 '10: 0.54 Q1 '11: 0.55 Q2 '11: 0.53 Q3 '11: 0.50 Q4 '11: 0.44 Q1 '12: 0.38 Q2 '12: 0.30 Q3 '12: 0.22 Q1 '14: -0.44 Q2 '14: -0.54 Q3 '14: -0.64 Q4 '14: -0.91 Q1 '15: -0.95 Q2 '15: -0.72 Q3 '15: -0.50 Q4 '15: -0.13 Q1 '16: -0.08 Q2 '16: -0.17 Q3 '16: -0.28 Q4 '16: -0.22 Q1 '17: -0.20 Q2 '17: -0.19 Q3 '17: -0.20 Q4 '17: -0.43 Q1 '18: -0.42 Q2 '18: -0.39 Q3 '18: -0.38 Q4 '18: -0.25 Q1 '19: -0.25 Q2 '19: -0.25 Q3 '19: -0.23 Q4 '19: -0.49 Q1 '20: -0.50 Q2 '20: -0.48 Q3 '20: -0.48 Q4 '20: -0.07 Q1 '21: -0.07 Q2 '21: -0.09 Q3 '21: -0.09 Q4 '21: -0.75 Q1 '22: -0.95 Q2 '22: -1.11 Q3 '22: -1.25 Q4 '22: -3.78 Q1 '23: -3.62 Q2 '23: -3.79 Q3 '23: -3.92 Q4 '23: -0.72 Q1 '24: -1.38 Q2 '24: -1.92 Q3 '24: -2.28 Q4 '24: -2.72 Q1 '25: -2.24 Q2 '25: -1.51 Q3 '25: -1.03 Q4 '25: -0.74 Q1 '26: -0.54 Q2 '26: -0.42 Q1 '11 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.